Company

Takeda Pharmaceutical Company

2022

Quick facts

5,734,000

Emissions (ton CO₂e)

29,990

Revenue (M USD)

191

Intensity (t CO₂e / M USD)

Ambition & Development

In 2022, Takeda Pharmaceutical Company reported a total of 5,734,000 ton CO₂e, and a net revenue of 29,990 M USD, resulting in a emissions intensity of 191 t CO₂e / M USD.

Targets

Base year:

2016

Target year:

2025

Reduction:

0.4

Classification:

1.5°C

Takeda Pharmaceutical Company commits to reduce absolute scope 1 and 2 GHG emissions 40% by FY2025 from a FY2016 base year.

Source: Science Based Target initative

Emissions, Revenue & Intensity

Emissions, Target & Trend

Report missing data

Revenue	2022
Net Revenue (M USD)	29,990
Revenue Source

Emissions Overview	2022
Total Emissions - Market Based (t CO₂e)
Emissions Intensity (t CO₂e / M USD)	191
Cradle-to-gate Intensity (t CO₂e / M USD)	19

Emissions Details	2022
Scope 1 Emissions (t CO₂e)	277,000
Scope 2 Emissions (t CO₂e)
Scope 2 - Market Based
Scope 2 - Location Based
Scope 2 - Not specified	291,000
Scope 3 Emissions (t CO₂e)	5,166,000
Upstream Emissions (t CO₂e)
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions (t CO₂e)
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions (t CO₂e)	5,734,000
Emission Source

Open Sustainability Index

Licensed under CC BY-SA 4.0